Verastem Inc Drug Patent Portfolio
Verastem Inc owns 1 orange book drug protected by 6 US patents Given below is the list of Verastem Inc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11873296 | Solid forms of a dual RAF/MEK inhibitor | 29 Dec, 2042 | Active |
| US11517573 | Therapeutic compositions, combinations, and methods of use | 11 Sep, 2040 | Active |
| US11400090 | Coumarin derivative for therapy or prophylaxis of a cell proliferative disorder | 29 Oct, 2038 | Active |
| US7928109 | Sulfonyl amide derivatives for the treatment of abnormal cell growth | 21 Aug, 2029 | Active |
| US8247411 | Sulfonyl amide derivatives for the treatment of abnormal cell growth | 17 Apr, 2028 | Active |
| US7897792 | Coumarin derivative having antitumor activity | 09 Feb, 2027 | Active |
Verastem Inc's Family Patents
Verastem Inc Drug List
Given below is the complete list of Verastem Inc's drugs and the patents protecting them.
1. Avmapki Fakzynja Co-pack (copackaged)
Avmapki Fakzynja Co-pack (copackaged) is protected by 6 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11873296 | Solid forms of a dual RAF/MEK inhibitor |
29 Dec, 2042
(17 years from now)
| Active |
| US11517573 | Therapeutic compositions, combinations, and methods of use |
11 Sep, 2040
(15 years from now)
| Active |
| US11400090 | Coumarin derivative for therapy or prophylaxis of a cell proliferative disorder |
29 Oct, 2038
(13 years from now)
| Active |
| US7928109 | Sulfonyl amide derivatives for the treatment of abnormal cell growth |
21 Aug, 2029
(4 years from now)
| Active |
| US8247411 | Sulfonyl amide derivatives for the treatment of abnormal cell growth |
17 Apr, 2028
(2 years from now)
| Active |
| US7897792 | Coumarin derivative having antitumor activity |
09 Feb, 2027
(1 year, 6 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Avmapki Fakzynja Co-pack (copackaged)'s drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List